Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 16, 2025
Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
May 16, 2025
Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the RNAfix® platform in CNS diseases Preclinical data showcases first demonstration of systemically …
Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews
GlobeNewswire
·
May 16, 2025
Perth, Western Australia, May 16, 2025 (GLOBE NEWSWIRE) -- Is enlargement and enhancing stamina and performance in bed with the growing age possible? Male health issues such as low stamina, low libido, frequent ejaculation, short performance, low cognitive …
Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick
GlobeNewswire
·
May 16, 2025
AURORA, Colo., May 16, 2025 (GLOBE NEWSWIRE) -- What This Review Will Cover The Underlying Inflammation Behind Neuropathic Pain and How Arialief Targets It The 7-Second Nerve Relief Trick: The actual steps behind using Arialief. Key Ingredient Analysis: …
Merus gibt die Veröffentlichung des Wirkmechanismus von Petosemtamab in der Fachpresse bekannt
GlobeNewswire
·
May 16, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, May 16, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, „das Unternehmen“, „wir“ oder „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper und Antikörper-Wirkstoff- …
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
GlobeNewswire
·
May 16, 2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …